Conteltinibtetrahydrochloride (CT-707 tetrahydrochloride) is the tetrahydrochloride form of Conteltinib. It acts as an inhibitor for FAK (IC50=1.6 nM), ALK, and Pyk2. When used in combination with Cabozantinib, Conteltinib tetrahydrochloride exhibits a synergistic antitumor effect.
Molecular Weight:
781.667
Formula:
C32H49Cl4N9O3S
Target:
FAK
T204589
* VAT and and shipping costs not included. Errors and price changes excepted